USA USA: 1-631-626-9181 Europe Europe: 44-207-097-1828  

Search

Tissue samples, tissue arrays, cells, microorganisms, probes and services for your research.

Web Search    Google
Featured Products
Ordering Information

Payment methods we support:
✭ Invoice / Purchase Order
✭ Credit card


IGH/MAF Dual Fusion Probe

  • Specification
  • Publications
  • Recommended Products
Cat.No.
FHPC-065
Description
The IGH/MAF Dual Fusion Probe is intended to detect the t(14;16)(q32;q23) reciprocal translocation involving the IGH and MAF gene regions.
MAF is an oncogene that has been found to be over-expressed in multiple myeloma (MM). Both MAF and WWOX genes are found in tandem on chromosome 16q23. t(14;16)(q32;q23) has been associated with more aggressive forms of MM. Thus, FISH testing for t(14;16)(q32;q23) has been indicated as one of the minimum tests during MM detection.
Size
20 Tests
Label
Red/Green
Locus
14q32/16q23
Specificity
Human
Usage
warningFor Research Use Only. Not for use in diagnostic procedures.
Storage
Store at minus 20 centigrade
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the Pub Med ID of your paper to get a coupon.
Method for the diagnosis, prognosis and treatment of prostate cancer metastasis: U.S. Patent Application 14/050,262[P]. Authors: Gomis R, Jean-Mairet J.
Method for the diagnosis, prognosis and treatment of lung cancer metastasis: U.S. Patent Application 14/405,724[P]. Authors: Gomis R, Planet E.
Method for the Prognosis and Treatment of Renal Cell Carcinoma Metastasis: U.S. Patent Application 14/776,390[P]. Authors: Gomis R, Lacey D L.
Method for the Prognosis and Treatment ofCancer Metastasis Authors: Gomis R, Planet E, Pavlovic M, et al.
Customer Support & Price Inquiry
Please input "bioarray" as verification code.
CONTACT US USA
45-1 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-626-9181
Fax: 1-631-614-7828
Email: 

Europe
Tel: 44-207-097-1828
Email: